Use of chimeric antigen receptor-modified T-cells to treat cancer
US-9499629-B2 · Nov 22, 2016 · US
Porter David L was listed as an assignee on 2 patent publications in 2016.
| Metric | Value |
|---|---|
| Company | Porter David L |
| Year | 2016 |
| Patents | 2 |
Representative publications for Porter David L in 2016.
US-9499629-B2 · Nov 22, 2016 · US
US-2016068601-A1 · Mar 10, 2016 · US
Most common classification codes for Porter David L in 2016.
| CPC | Patents |
|---|---|
| A61K2039/505 | 2 |
| A61K2039/5156 | 2 |
| A61K2239/31 | 2 |
| A61K2239/38 | 2 |
| A61K2239/48 | 2 |
Navigate to parent entity pages.